Synergistic In Vitro Antimalarial Activity of Omeprazole and Quinine

Por Skinner-Adams, T., Davis, T. M. E.
Publicado em 1999

Drug repurposing and human parasitic protozoan diseases

Por Andrews, Katherine T., Fisher, Gillian, Skinner-Adams, Tina S.
Publicado em 2014

Synergistic Interactions of the Antiretroviral Protease Inhibitors Saquinavir and Ritonavir with Chloroquine and Mefloquine against Plasmodium falciparum In Vitro

Por Skinner-Adams, T. S., Andrews, K. T., Melville, L., McCarthy, J., Gardiner, D. L.
Publicado em 2007

Activity of bromodomain protein inhibitors/binders against asexual-stage Plasmodium falciparum parasites

Por Chua, Ming Jang, Robaa, Dina, Skinner-Adams, Tina S., Sippl, Wolfgang, Andrews, Katherine T.
Publicado no Int J Parasitol Drugs Drug Resist (2018)

An ELISA method to assess HDAC inhibitor-induced alterations to P. falciparum histone lysine acetylation

Por Hesping, Eva, Skinner-Adams, Tina S., Fisher, Gillian M., Kurz, Thomas, Andrews, Katherine T.
Publicado no Int J Parasitol Drugs Drug Resist (2020)

Comparison of Plasmodium falciparum transfection methods

Por Skinner-Adams, Tina S, Lawrie, Paula M, Hawthorne, Paula L, Gardiner, Donald L, Trenholme, Katharine R
Publicado em 2003

Saquinavir Inhibits the Malaria Parasite's Chloroquine Resistance Transporter

Por Martin, Rowena E., Butterworth, Alice S., Gardiner, Donald L., Kirk, Kiaran, McCarthy, James S., Skinner-Adams, Tina S.
Publicado em 2012

A novel in vitro image-based assay identifies new drug leads for giardiasis

Por Hart, Christopher J.S., Munro, Taylah, Andrews, Katherine T., Ryan, John H., Riches, Andrew G., Skinner-Adams, Tina S.
Publicado no Int J Parasitol Drugs Drug Resist (2017)

An image-based Pathogen Box screen identifies new compounds with anti-Giardia activity and highlights the importance of assay choice in phenotypic drug discovery

Por Tiash, Snigdha, Saunders, Jake, Hart, Christopher J.S., Ryan, John H., Riches, Andrew G., Skinner-Adams, Tina S.
Publicado no Int J Parasitol Drugs Drug Resist (2020)

Synthesis and Antiplasmodial Evaluation of Analogues Based on the Tricyclic Core of Thiaplakortones A–D

Por Schwartz, Brett D., Coster, Mark J., Skinner-Adams, Tina S., Andrews, Katherine T., White, Jonathan M., Davis, Rohan A.
Publicado no Mar Drugs (2015)

Adaptation of the [(3)H]Hypoxanthine Uptake Assay for In Vitro-Cultured Plasmodium knowlesi Malaria Parasites

Por Arnold, Megan S. J., Engel, Jessica A., Chua, Ming Jang, Fisher, Gillian M., Skinner-Adams, Tina S., Andrews, Katherine T.
Publicado no Antimicrob Agents Chemother (2016)

Potent Antimalarial Activity of Histone Deacetylase Inhibitor Analogues

Por Andrews, K. T., Tran, T. N., Lucke, A. J., Kahnberg, P., Le, G. T., Boyle, G. M., Gardiner, D. L., Skinner-Adams, T. S., Fairlie, D. P.
Publicado em 2008

Erratum to “Profiling the anti-protozoal activity of anti-cancer HDAC inhibitors against Plasmodium and Trypanosoma parasites” [Int. J. Parasitol. Drugs Drug Res. 5 (2015) 117–126]...

Por Engel, Jessica A., Jones, Amy J., Avery, Vicky M., Sumanadasa, Subathdrage D.M., Ng, Susanna S., Fairlie, David P., Skinner-Adams, Tina, Andrews, Katherine T.
Publicado no Int J Parasitol Drugs Drug Resist (2016)

Antimalarial Asexual Stage-Specific and Gametocytocidal Activities of HIV Protease Inhibitors

Por Peatey, Christopher L., Andrews, Katherine T., Eickel, Nina, MacDonald, Timothy, Butterworth, Alice S., Trenholme, Katharine R., Gardiner, Donald L., McCarthy, James S., Skinner-Adams, Tina S.
Publicado em 2010

Fingerprinting the Substrate Specificity of M1 and M17 Aminopeptidases of Human Malaria, Plasmodium falciparum

Por Poreba, Marcin, McGowan, Sheena, Skinner-Adams, Tina S., Trenholme, Katharine R., Gardiner, Donald L., Whisstock, James C., To, Joyce, Salvesen, Guy S., Dalton, John P., Drag, Marcin
Publicado em 2012

Effect of clinically approved HDAC inhibitors on Plasmodium, Leishmania and Schistosoma parasite growth

Por Ming Jang Chua, Megan S.J. Arnold, Weijun Xu, Julien Lancelot, Suzanne Lamotte, Gerald F. Späth, Eric Prina, Raymond J. Pierce, David P. Fairlie, Tina S. Skinner-Adams, Katherine T. Andrews
Publicado em 2017-04-01

Antimalarial Activity of the Anticancer Histone Deacetylase Inhibitor SB939

Por Sumanadasa, Subathdrage D. M., Goodman, Christopher D., Lucke, Andrew J., Skinner-Adams, Tina, Sahama, Ishani, Haque, Ashraful, Do, Tram Anh, McFadden, Geoffrey I., Fairlie, David P., Andrews, Katherine T.
Publicado em 2012

Effect of clinically approved HDAC inhibitors on Plasmodium, Leishmania and Schistosoma parasite growth

Por Chua, Ming Jang, Arnold, Megan S.J., Xu, Weijun, Lancelot, Julien, Lamotte, Suzanne, Späth, Gerald F., Prina, Eric, Pierce, Raymond J., Fairlie, David P., Skinner-Adams, Tina S., Andrews, Katherine T.
Publicado no Int J Parasitol Drugs Drug Resist (2016)

Anti-malaria drug development targeting the M1 alanyl and M17 leucyl aminopeptidases

Por Karine Thivierge, Rency T. Mathew, Desire M. M. Nsangou, Fabio Da Silva, Sophie Cotton, Tina S. Skinner-Adams, Katharine R. Trenholme, Christopher L. Brown, Colin M. Stack, Donald L. Gardiner, John P. Dalton
Publicado em 2012-06-01

The Aminopeptidase Inhibitor CHR-2863 Is an Orally Bioavailable Inhibitor of Murine Malaria

Por Skinner-Adams, Tina S., Peatey, Christopher L., Anderson, Karen, Trenholme, Katharine R., Krige, David, Brown, Christopher L., Stack, Colin, Nsangou, Desire M. M., Mathews, Rency T., Thivierge, Karine, Dalton, John P., Gardiner, Donald L.
Publicado em 2012